Results of Dasatinib Therapy in Patients With Early Chronic-Phase Chronic Myeloid Leukemia

PURPOSE: Dasatinib is effective therapy for chronic myeloid leukemia (CML) after imatinib failure. In this study, we investigate the efficacy of dasatinib as initial therapy for patients with CML in early chronic phase. PATIENTS AND METHODS: Patients with newly diagnosed CML in early chronic phase w...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Cortes, Jorge E., Jones, Dan, O'Brien, Susan, Jabbour, Elias, Ravandi, Farhad, Koller, Charles, Borthakur, Gautam, Walker, Brenda, Zhao, Weiqiang, Shan, Jianqin, Kantarjian, Hagop
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2010
Sujets:
Original Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2815702/
https://ncbi.nlm.nih.gov/pubmed/20008620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.4920
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires